Andreas Halvorsen acquired 5.15 Million Viking Therapeutics shares worth $411 Million. That's 1.46% of their equity portfolio (23rd largest holding). The investor owns 4.92% of the outstanding Viking Therapeutics stock. The stake costed the investor $75.7 Million, netting the investor a gain of 443% so far.